Shares of Minerva Neurosciences, Inc (NASDAQ:NERV - Get Free Report) have been assigned a consensus recommendation of "Reduce" from the four brokerages that are presently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, one has g